| Dear Voornaam
In the year since we launched our Research Data Strategy weve made great progress toward our goal of maximising the scientific value of data for cancer research.
Were creating a community of data experts through hosting workshops and events such as our new webinar series and our inaugural data conference next February. Weve built partnerships with Health Data Research UK and other data centred organisations. And weve supported patient and public involvement through collaboration with advocacy groups such as use MY data.
Weve also begun shaping our cancer data driven detection programme to combine the strengths of our multidisciplinary research community to help us prevent, detect and diagnose cancer.
And now on the first anniversary of our data strategy, were launching our new trusted research programme to offer data research and information governance advice and infrastructure that ensures you have the support you need to safely and effectively collect and reuse sensitive cancer data.
Find out more about the full scope of this new programme and how to access advisory services or our secure trusted research environment. |
|
|---|
|
|---|
|
|
Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
MEET OUR NEWEST GRANT AWARDEES Were excited to announce the latest grant awardees selected by our Clinical Research Committee in the March funding round:
- Reuben Benjamin, Charlotte Graham, John Maher and Christina Yap were awarded a Clinical Trial Award to run a phase 1 study to evaluate pCAR19
- Darren Hargrave received a Clinical Trial Award to investigate the efficacy of ONC201 in combination with radiotherapy in a phase 3 trial
- Elizabeth Phillips and Kim Linton received a Sample Collection Award to discover biomarkers in early-stage Hodgkin Lymphoma
Join us in congratulating our new grant holders on social media by following along with the hashtag #CRUKFunded. |
|
|---|
|
|---|
|
|
 NEW EDITORIAL WEBSITE FOR RESEARCHERS Weve launched a new editorial hub to host in depth articles, podcasts, analysis and interviews. Browse the platform to explore interesting questions in cancer science, how it shapes our understanding of the disease and read the sharpest insights from our cancer research community on conducting research.
If you have an idea for a story, would like to be featured or want to contribute in some way, please get in touch. |
|
|---|
|  THERAPEUTIC RADIOGRAPHY: WHERE THEORY MEETS PRACTICE How are therapeutic radiographers making a difference in not only outcomes for patients but also their experiences living with and beyond cancer?
In our latest research blog, guest author Will Kinnaird and other leading radiographers share how leveraging their unique position at the intersection of science and patient impact is paving the way for a more empathetic, tailored and effective approach to cancer care. |
|
|---|
|
|---|
|
|
SUBMIT A NOMINATION FOR THIS YEARS DON LISTWIN AWARD Do you know a colleague or team who has contributed to the field of cancer early detection through an outstanding commitment or a singular achievement?
Nominate them for this years Don Listwin award to recognise and celebrate them for their work at our international early detection of cancer conference in October.
Previous winners include Sudhir Srivastava (NCI), Rebecca Fitzgerald (University of Cambridge) and Sanjiv Sam Gambhir (Canary Center at Stanford). |
|
|---|
|
|---|
|
|
 LAST CHANCE TO TAKE PART IN THE VENTURE BUILDER INCUBATOR Join Cancer Research Horizons and the University of Edinburghs Venture Builder Incubator to gain the skills and knowledge to maximise the impact of your research and develop your own data-driven startup.
The curated programme will give you access to a share of over 65k and includes interactive workshops and events, one-to-one support and links to investors to help you develop a robust commercialisation strategy. |
|
|---|
|  SHOWCASE YOUR RESEARCH AT MAP 2023 CONGRESS Do you want to showcase your work alongside experts in molecular profiling and precision medicine?
MAP 2023 Congress is uniting researchers in clinical and precision oncology for three days of thought-provoking scientific discussion with the opportunity to present your research as part of the conference programme.
Submit an abstract by 25 July for the chance to give a proffered talk or present a poster. |
|
|---|
|
|---|
|
|
NEW IN THE LANCET: RADIOTHERAPY IN EARLY BREAST CANCER Results from the phase 3 IMPORT HIGH trial, published in The Lancet, show that giving some breast cancer patients a targeted additional dose of radiotherapy at the same time as treatment to the whole breast cuts the time taken to complete treatment by at least a week.
Charlotte Coles et al tested simultaneous integrated tumour-bed boost delivered after whole-breast radiotherapy against sequential boost with the aim of reducing treatment duration while maintaining local cancer-control and toxicity.
2,617 patients were randomly allocated to receive one of three treatments. In all groups, 5-year ipsilateral breast tumour relapse incidence was lower than expected regardless of boost sequencing. The authors also found that adverse event rates were low using small boost volumes and that simultaneous integrated boost was safe and reduced patient visits. |
|
|---|
|
|---|
|
|
 75 YEARS OF NHS CANCER CARE From the first clinical trial testing lumpectomies for breast cancer to introducing Tamoxifen, the HPV vaccine and CAR-T cell therapy research, technology and data have transformed NHS cancer care over the last seven decades.
Todays NHS is seeing more people with suspected cancer than ever before. Its also diagnosing more cancers earlier and helping more people survive the disease. But the NHS is also under serious pressure and facing a crisis in its workforce.
The NHS needs investment and reform to keep up, and were uniquely placed to help with that. |
|
|---|
|  OUR QUESTIONS ON THE NHS LONG TERM WORKFORCE PLAN FOR ENGLAND The recently published NHS workforce plan for England is a welcome step in the right direction to address the services staffing issues and waiting times.
The plan promises more investment in training, commitments on cancer and to regularly refresh the plan to integrate advances in technology and treatments.
Yet, the plan does not go far enough to address the full scale of the challenge on recruitment or retention. It also fails to include detailed estimates of growth needed for key professionals and how to increase staff numbers in the key specialties essential to the diagnosis and treatment of cancer. |
|
|---|
|
|---|
|
|
BECOME A HEALTHTECH LEADER WITH KQ LABS Cancer Research Horizons, our innovation arm, is sponsoring one promising early-stage startup focused on cancer as part of the Francis Crick Institutes KQ Labs.
The accelerator programme will provide you with expert mentorship from accomplished professionals with expertise in HealthTech, data science and entrepreneurship, as well as tailored introductions to relevant industry partners, investors and potential clients.
By joining the programme, you will receive 40k funding in the form of a convertible loan, invaluable insights, as well as access to our network and expertise. Apply by 10 July 2023. |
|
|---|
|
|---|
|
|
| | | Glasgow, UK 11 September 2023 |
|
|---|
|
|---|
| | | Online 4:00 PM 27 September 2023 |
|
|---|
|
|---|
| | | Paris, France 04 October 2023 |
|
|---|
|
|---|
| | | London, UK 10 October 2023 |
|
|---|
|
|---|
| | | Liverpool, UK 18 October 2023 |
|
|---|
|
|---|
| | | London, UK 14 November 2023 |
|
|---|
|
|---|
| | | London, UK 21 November 2023 |
|
|---|
|
|---|
| | | Manchester, UK 27 February 2024 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
